Cerebrospinal fluid biomarker for Parkinson's disease: An overview

Alzheimer’s Disease

Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid.

JAMA Neurol.

Shahnawaz M, Tokuda T, Waragai M, Mendez N, Ishii R, Trenkwalder C, Mollenhauer B, Soto C

doi: 10.1001/jamaneurol.

Aging and Cognitive FunctionsAlzheimer’s DiseaseMultiple Sclerosis

Alzheimer disease pathology and the cerebrospinal fluid proteome

Alzheimers Res Ther.

Dayon L, Núñez Galindo A, Wojcik J, Cominetti O, Corthésy J, Oikonomidi A, Henry H, Kussmann M, Migliavacca E, Severin I, Bowman GL, Popp J

doi: 10.1186/s13195-018-0397-4.

Multiple Sclerosis

Cerebrospinal fluid complement system biomarkers in demyelinating disease

Mult Scler.

Zelek WM, Fathalla D, Morgan A, Touchard S, Loveless S, Tallantyre E, Robertson NP, Morgan BP

doi: 10.1177/1352458519887905.

Multiple Sclerosis

Soluble CD27 Levels in Cerebrospinal Fluid as a Prognostic Biomarker in Clinically Isolated Syndrome

JAMA Neurol.

van der Vuurst de Vries RM, Mescheriakova JY, Runia TF, Jafari N, Siepman TA, Hintzen RQ

doi: 10.1001/jamaneurol.

RECOMMENDED

Parkinson’s Disease

CSF and blood biomarkers for Parkinson's disease

Lancet Neurol.

Parnetti L, Gaetani L, Eusebi P, Paciotti S, Hansson O, El-Agnaf O, Mollenhauer B, Blennow K, Calabresi P

doi: 10.1016/S1474-4422(19)30024-9.

COMMENTED

Aging and Cognitive Functions

Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders

JAMA Neurol.

Olsson B, Portelius E, Cullen NC, Sandelius Å, Zetterberg H, Andreasson U, Höglund K, Irwin DJ, Grossman M, Weintraub D, Chen-Plotkin A, Wolk D, McCluskey L, Elman L, Shaw LM, Toledo JB, McBride J, Hernandez-Con P, Lee VM, Trojanowski JQ, Blennow K

doi: 10.1001/jamaneurol.

Association of Cerebrospinal Fluid Biomarkers of Central Nervous System Injury With Neurocognitive and Brain Imaging Outcomes in Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia

JAMA Oncol.

Cheung YT, Khan RB, Liu W, Brinkman TM, Edelmann MN, Reddick WE, Pei D, Panoskaltsis-Mortari A, Srivastava D, Cheng C, Robison LL, Hudson MM, Pui CH, Krull KR

doi: 10.1001/

Multiple Sclerosis

In search of cerebrospinal fluid biomarkers of fatigue in multiple sclerosis: A proteomics study

J Sleep Res.

Valko PO, Roschitzki B, Faigle W, Grossmann J, Panse C, Biro P, Dambach M, Spahn DR, Weller M, Martin R, Baumann CR

doi: 10.1111/jsr.12721.

Alzheimer’s Disease

FTIR Spectroscopy of Cerebrospinal Fluid Reveals Variations in the Lipid: Protein Ratio at Different Stages of Alzheimer's Disease

J Alzheimers Dis.

Depciuch J, Zawlik I, Skrzypa M, Pająk J, Potocka N, Łach K, Bartosik-Psujek H, Koziorowska A, Kaznowska E, Cebulski J

doi: 10.3233/JAD-

Related content

Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid.

Alzheimer disease pathology and the cerebrospinal fluid proteome

Cerebrospinal fluid complement system biomarkers in demyelinating disease

Soluble CD27 Levels in Cerebrospinal Fluid as a Prognostic Biomarker in Clinically Isolated Syndrome

CSF and blood biomarkers for Parkinson's disease

Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders

Association of Cerebrospinal Fluid Biomarkers of Central Nervous System Injury With Neurocognitive and Brain Imaging Outcomes in Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia

In search of cerebrospinal fluid biomarkers of fatigue in multiple sclerosis: A proteomics study

FTIR Spectroscopy of Cerebrospinal Fluid Reveals Variations in the Lipid: Protein Ratio at Different Stages of Alzheimer's Disease